Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Taps Russo as New CFO; Bethlendy Joins BioForce from Combimatrix; Entelos Hires Rigsbee as General Counsel; and Others

Accelrys has appointed Rick Russo as senior vice president and CFO.
Russo most recently served as CFO of Captiva Software, a provider of automatic data capture software that was acquired by EMC in December 2005.
Russo replaces David Sankaran, who resigned as senior vice president and CFO of Accelrys in June.

BioForce Nanosciences has named Gabor Bethlendy sales manager for Europe. He will be based in Boston, Mass.
Bethlendy joins BioForce from Combimatrix, where he was regional sales manager for the company’s custom microarray and array synthesizer product lines. Prior to that, Bethlendy was senior application scientist for Agilent Technologies.

John Rigsbee has joined Entelos as general counsel. In this role, Rigsbee will advise the company regarding intellectual property, technology transfer, licensing, and general corporate matters.
Rigsbee joins Entelos from Jazz Pharmaceuticals, where he served as corporate counsel and was responsible for providing legal advice to support R&D, licensing and acquisitions, sales and marketing, medical affairs, and clinical affairs. Prior to that, Rigsbee served as corporate counsel at Tularik and as an attorney with Venture Law Group and Townsend and Townsend and Crew.

Gene Express has appointed Nick Lazaridis as president.
Lazaridis most recently served as senior vice president of preclinical services at AAI Pharma. Prior to that, he was senior vice president of Laboratory Services for AAI Development Services.

Xenomics has named David Sidransky, director of the Head and Neck Cancer Research Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, to its board of directors.
Sidransky is also a professor of Oncology, Urology, Cellular & Molecular Medicine, Pathology, Otolaryngology and Genetics at Johns Hopkins School of Medicine. He has served on the scientific advisory boards of Medimmune, Roche, and Amgen, and is a former member of the Recombinant DNA Advisory Committee at the National Institutes of Health. He is currently vice chairman of the board of ImClone Systems.
Xenomics is a molecular diagnostic company that focuses on the development of DNA-based tests using transrenal DNA.

Aureus Pharma has tapped Jason Theodosiou as chief operating officer and as a member of the company’s board of directors.
Theodosiou was most recently vice president for global business at Elsevier MDL and at Lion Biosciences. He also held the position of general manager for European operations at EMAX/SciQUEST.

Protagen has expanded its board of directors from three to five members. The two new members are Michael Motschmann, representing the MIG AG & Co Funds and 3 KG, and Gerhard Steinkamp from S-VentureCapital Dortmund.
The company has reappointed Axel Kleemann as chairman of the board.
The sixth seat on the board will be left unoccupied. Protagen said it plans to appoint “an expert from the protein biochip field” to that spot in the near future.

BioDelivery Sciences has appointed Thomas D’Alonzo to its board of directors.
D’Alonzo has held several positions, including president, at Glaxo, the US subsidiary of the former Glaxo Holdings. He was also president and CEO of GenVec.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.